|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 310 studies with search of: | Tenofovir[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
|
||||
| 2 | Active, not recruiting |
Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Efavirenz/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
|
||||
| 3 | Active, not recruiting |
Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
|
||||
| 4 | Recruiting |
Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV 1 Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 5 | Recruiting |
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
|
||||
| 6 | Active, not recruiting |
Study of the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 (QUAD) Versus Atripla(R) in HIV Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 7 | Active, not recruiting |
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
|
||||
| 8 | Recruiting |
Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
|
||||
| 9 | Withdrawn |
Raltegravir Activity In Lymphoid Tissues
|
||||
| 10 | Completed |
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
|
||||
| 11 | Completed |
Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients
|
||||
| 12 | Unknown † |
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
|
||||
| 13 | Completed |
Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
|
||||
| 14 |
Active, not recruiting
Has Results |
Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy
|
||||
| 15 | Unknown † |
Bangkok Tenofovir Study
|
||||
| 16 | Active, not recruiting |
Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
|
||||
| 17 | Active, not recruiting |
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
|
||||
| 18 | Completed |
Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
|
||||
| 19 | Recruiting |
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
|
||||
| 20 | Completed |
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|